Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Sleep Apnea, Obstructive 1Rhinitis, Allergic, Seasonal 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1Mesothelioma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Hypertension, Pulmonary 1Emphysema 1Cystic Fibrosis 1Bronchiectasis 1Asthma 1Asbestosis 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Sulfur Hexafluoride × Clear all
NCT02748798 2024-10-15

Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders

Thunder Bay Regional Health Research Institute

Phase EARLY_PHASE1 Terminated
10 enrolled
Other solid neoplasmThoracic

Asbestosis, Asthma, Bronchiectasis, Cystic Fibrosis, Emphysema, Rhinitis, Allergic, Seasonal, Hypertension, Pulmonary, Lung Neoplasms, Mesothelioma, Pulmonary Embolism, Pulmonary Fibrosis, Lung Diseases, Interstitial, Sleep Apnea, Obstructive, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡